Longwood creates and invests in science-based companies that develop novel solutions for important medical problems.

Grail

PTC Therapeutics

Pyxis Oncology

Werewolf Therapeutics

ArcherDX

Millendo Therapeutics

Bicycle Therapeutics

Calithera Biosciences

Colorescience

KalVista Pharmaceuticals

TScan Therapeutics

Verastem Oncology

Longwood Fund

Longwood Healthcare Leaders Stanford/San Francisco CEO, January 6-7, 2024 brings together a select group of biopharma leaders, and top biotech and pharma CEOs. https://conta.cc/45B3JsP

Join us January 6-7 for Longwood Healthcare Leaders Stanford/San Francisco CEO to hear from senior-level executives in #biopharma
See more: https://lnkd.in/euXm7nR7

Congratulations to Sitryx on the recent raise, bringing the total to over $75M to develop disease-modifying therapeutics in #autoimmune and #inflammatroy diseases https://lnkd.in/evPXBZug

Important progress for #patients #autism #asd

Read the release here: https://lnkd.in/eeQS_C_W

More than ever, we must evolve how we think and work to increase speed and success in progressing potential therapies from concept to clinic. But what are the key challenges in evolving R&D models and how can we overcome them? At the #LongwoodHealthcareLeaders Fall 2023 Harvard Conference, I participated in a panel focusing on R&D transformation, exploring how we can discover novel therapeutic targets and get them to patients faster. My top takeaways were:
1.      Scaling change and making it stick depends on thinking beyond cost and speed to ensure changes are sustainable and empowering for teams: It takes time and effort to reframe mindsets and behaviors. New models and structures must be designed to accelerate innovation, maximize the skills of our talent in the right place at the right time and enhance cross-collaboration. 
2.      Digital transformation should sit at the core of any R&D strategy: Smart use of AI and human genomics data will increase our speed and probability of success in drug discovery and development and get new therapies to patients faster. At Astellas, we aim to build the best possible relationship between people and digital technology to achieve what has been unattainable until now.
3.      Partnering across the innovation community and with regulators will always be critical to our success: New modalities pose several complex challenges that can’t be navigated alone. We must collaborate across our communities, including industry, academia, and regulators, to break these challenges down and solve them quickly. 
What got us to where we are today won’t be enough to deliver the innovations of tomorrow. By evolving our R&D approach, we can collectively navigate the fast-moving healthcare landscape and transform the lives of patients. #ScienceFirstForPatients #Changingtomorrow

Wonderful learning about innovative commercial models with Moderna Arpa Garay, Akili Labs Eddie Martucci, Ocugen Michael Shine, Ovid Therapeutics Jason Tardio & Klick Brian Fox! #longwoodhealthcareleaders

MPM BioImpact Inc is a healthcare venture capital firm that invests in biotechnology, medical devices, and health tech companies.

MPM BioImpact Inc

Delphi Ventures is a healthcare venture capital firm specializing in funding and building healthcare companies.

Delphi Ventures

Atlas Venture GmbH is a healthcare venture capital firm that partners with entrepreneurs to create and finance healthcare companies.

Atlas Venture GmbH

The Column Group Inc is a healthcare venture capital firm that focuses on investing in biotechnology and life sciences companies.

The Column Group Inc

The Engine is a venture capital firm that supports early-stage companies working on tough technology challenges.

The Engine

Asymmetric and Omega Funds are healthcare venture capital firms that invest in innovative healthcare companies.

Asymmetric and Omega Funds

Abingworth is a leading international investment group dedicated to investing in life sciences and healthcare.

Abingworth

Alpha Growth is a healthcare venture capital firm that invests in companies focused on driving innovation in healthcare.

Alpha Growth

CM Life Sciences is a venture capital firm that invests in life sciences and healthcare companies.

CM Life Sciences

Principia SGR is a healthcare venture capital firm that focuses on investing in innovative healthcare companies.

Principia SGR

NetScientific is a global investment group that invests in and manages early and growth-stage healthcare and technology companies.

NetScientific

Longwood Fund is a leading healthcare venture capital firm that founds, manages, and builds healthcare companies. The firm partners with entrepreneurs to create, finance, and build healthcare companies that make a meaningful difference in the treatment of disease and improve the lives of patients. Their portfolio companies focus on a variety of healthcare subsectors, including biotechnology, medical devices, and health tech.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

news impact assignment basic	general
public peers	general	May 11, 2024 1:02 AM	4510cead
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	2455704a
crunchbase profile	general
li profile	general	May 11, 2024 1:02 AM	98d37319
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:LONGWOODFUND

Longwood Fund